# Serum Institute of India

Source: https://onco.cc/companies/serum-institute-of-india/  
OnCo record `serum-institute-of-india` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The world's largest vaccine maker by doses, which developed CERVAVAC, India's first home-made HPV vaccine, so that cervical cancer prevention no longer depends on imported shots.

## Summary

The Serum Institute of India was founded in 1966 in Pune and makes more vaccine doses than any other company. With support from the Department of Biotechnology it developed CERVAVAC, a quadrivalent HPV vaccine against types 6, 11, 16 and 18 produced in Hansenula polymorpha yeast, indicated for girls and women aged 9 to 26 (cervical, vulvar, vaginal and anal cancer and genital warts) and boys and men aged 9 to 26 (anal cancer and genital warts), given as two doses at 0 and 6 months for ages 9 to 14 and three doses for ages 15 to 26. CERVAVAC received Indian market authorisation in 2022 and was introduced in 2023; published comparisons report immunogenicity non-inferior to established vaccines, and it is the intended supply for India's planned national HPV vaccination programme.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Pune
- Type: pharma
- Website: https://www.seruminstitute.com

## Sources

- Official website: https://www.seruminstitute.com
- CERVAVAC product page: https://www.seruminstitute.com/product_ind_cervavac.php

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/)
- drugs: [CERVAVAC (quadrivalent HPV vaccine, India)](https://onco.cc/drugs/cervavac/), [Nonavalent HPV vaccine](https://onco.cc/drugs/gardasil-9/)
- institutions: [Department of Biotechnology, Government of India](https://onco.cc/institutions/dbt-india/)
- bottlenecks: [Most of the world has almost no cancer care](https://onco.cc/bottlenecks/b-global-access/), [Prevention we already have is not deployed](https://onco.cc/bottlenecks/b-prevention-adoption/)
- roadmaps: [Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers](https://onco.cc/roadmaps/prevention-roadmap/), [Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation](https://onco.cc/roadmaps/global-access-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/serum-institute-of-india.json